Viewing Study NCT06344793


Ignite Creation Date: 2025-12-25 @ 1:19 AM
Ignite Modification Date: 2026-01-05 @ 11:38 PM
Study NCT ID: NCT06344793
Status: COMPLETED
Last Update Posted: 2025-07-28
First Post: 2024-03-28
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Initial CDK 4/6 Inhibitor Plus Endocrine Therapy Versus Initial Chemotherapy in HR Positive, HER2 Negative Unresectable or Metastatic Breast Cancer
Sponsor: Fudan University
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module